ACC/AHA与ESC/EACTS瓣膜性心脏病指南对比解读
该综述对比了ACC/AHA与ESC/EACTS最新瓣膜性心脏病管理指南的一致性与差异。两套指南总体一致,但存在对临床实践有重要影响的关键差异。文章还指出了指南中的证据空白及未来研究方向。
要点
- 两套指南在瓣膜性心脏病管理上总体一致,但存在重要差异。
- 差异对临床实践有显著影响,需结合具体情境解读。
- 指南存在证据空白,未来研究应填补这些缺口。
核心结论
- ACC/AHA与ESC/EACTS瓣膜性心脏病指南总体一致,但存在对临床实践有重要影响的实质性差异。
研究设计与样本
- 该文为ACC/AHA与ESC/EACTS瓣膜性心脏病指南的对比综述,由EuroValve Consortium组织撰写。
主要发现
- 两套指南在瓣膜性心脏病管理上总体一致,但存在若干实质性差异。
- 这些差异可能对临床实践产生显著影响。
- 指南中存在证据空白,需未来研究填补。
临床怎么用
- 临床医生应了解两套指南的一致性与差异,以优化瓣膜性心脏病患者管理。
局限性
- 原文未报告具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.
引用
- Coisne A, Lancellotti P, Habib G, et al. ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison. J Am Coll Cardiol. 2023. PMID: 37587584. doi:10.1016/j.jacc.2023.05.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。